Location History:
- Givat Shmuel, IL (2015)
- Tel Aviv, IL (2015)
- Ramat Gan, IL (2018)
Company Filing History:
Years Active: 2015-2018
Title: Dov Terkieltaub: Innovator in Urinary and Cervical Cancer Diagnostics
Introduction
Dov Terkieltaub is a notable inventor based in Ramat Gan, Israel. He has made significant contributions to the field of medical diagnostics, particularly in the areas of urinary system and cervical cancer cell analysis. With a total of 3 patents to his name, Terkieltaub's work is paving the way for advancements in cancer detection and treatment.
Latest Patents
Terkieltaub's latest patents include innovative methods and kits for differential staining of abnormal urinary system cells. These methods involve contacting cells or samples with a combination of an extract from a plant, an acidic dye, and a basic dye to identify abnormal urinary system cells effectively. Another significant patent focuses on methods and kits for staining cervical cancer cells and tissues. This involves using a plant extract and specific dyes to diagnose pre-malignant or malignant cervical tumors by identifying cervical cells with distinct staining characteristics.
Career Highlights
Throughout his career, Terkieltaub has been associated with Zetiq Technologies Ltd., where he has played a crucial role in developing diagnostic tools that enhance the accuracy of cancer detection. His innovative approaches have garnered attention in the medical community, contributing to improved patient outcomes.
Collaborations
Terkieltaub has worked alongside talented colleagues such as Adi Elkeles and Pavel Idelevich. Their collaborative efforts have further advanced the research and development of diagnostic methods in their field.
Conclusion
Dov Terkieltaub's contributions to medical diagnostics, particularly in urinary and cervical cancer detection, highlight his innovative spirit and dedication to improving healthcare. His patents represent a significant step forward in the fight against cancer, showcasing the importance of research and development in medical technology.